{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:23:03Z","timestamp":1783606983058,"version":"3.55.0"},"reference-count":20,"publisher":"Bioscientifica","issue":"2","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":138,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:p>Telomerase reverse transcriptase promoter mutations (TERT) are known prognostic factors associated with poor outcomes in differentiated thyroid carcinoma (DTC). We analyzed differences in DTC recurrence patterns over time according to TERT. A retrospective review was conducted on DTC patients who achieved remission after total thyroidectomy and\/or radioactive iodine treatment at Samsung Medical Center between 1994 and 2004. The sites and patterns by time of recurrence in the patients were reviewed. In total, 367 patients with a median follow-up of 14 years (interquartile range, 12\u201317 years) were included. Recurrence occurred in 91 patients, wherein 56 had lymph node recurrence and 35 had either local or distant recurrence. TERT and tumor size &amp;lt;2 cm were independent factors for recurrence in the Cox proportional hazards analysis. In cases of TERT-wild type (WT), the recurrence rate decreased significantly over time after diagnosis, whereas in TERT-mutant type (MT), a consistently high recurrence rate was observed. In the Kaplan\u2013Meier analysis, TERT-MT exhibited a significantly poorer disease-free survival, with continuous recurrence over time, whereas in TERT-WT, the curve showed a gradual decline. Further analysis of the overall survival among the 91 patients revealed that TERT-MT was significantly associated with a higher risk of mortality, whereas TERT-WT exhibited a slowly decreasing curve. In conclusion, TERT-MT was a significant adverse prognostic factor wherein continuous recurrence necessitates long-term follow-up. For TERT-WT, the recurrence rate decreased compared to TERT-MT, and even in cases of recurrence, the treatment outcomes are favorable.<\/jats:p>","DOI":"10.1530\/erc-25-0273","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T17:13:06Z","timestamp":1769620386000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["<i>TERT<\/i>\n                    promoter mutations and recurrence patterns in differentiated thyroid carcinoma"],"prefix":"10.1530","volume":"33","author":[{"given":"Hyun Jin","family":"Ryu","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Yoo","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Eun","family":"Leem","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Seok","family":"Ki","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hee","family":"Shin","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Lyun","family":"Oh","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Han","family":"Kim","sequence":"additional","affiliation":[{"name":"7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Jun","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Jeung","family":"Ahn","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonghyun","family":"Ahn","sequence":"additional","affiliation":[{"name":"8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Wook","family":"Kim","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hoon","family":"Chung","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7975-2437","authenticated-orcid":true,"given":"Tae Hyuk","family":"Kim","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-8085","authenticated-orcid":true,"given":"Young Ik","family":"Son","sequence":"additional","affiliation":[{"name":"9"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"2026070909465188000_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/thy.2021.0662","article-title":"Thyroid cancer incidence and mortality trends in the United States: 2000\u20132018","volume":"32","author":"Megwalu","year":"2022","journal-title":"Thyroid"},{"key":"2026070909465188000_bib2","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2018052","article-title":"National epidemiologic survey of thyroid cancer (NEST) in Korea","volume":"40","author":"Oh","year":"2018","journal-title":"Epidemiol Health"},{"key":"2026070909465188000_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070909465188000_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2026070909465188000_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/thy.2012.0654","article-title":"Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors","volume":"24","author":"Cho","year":"2014","journal-title":"Thyroid"},{"key":"2026070909465188000_bib6","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"key":"2026070909465188000_bib7","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1210\/jc.2015-2690","article-title":"Association of TERT promoter mutation, but not BRAF mutation, with increased mortality in PTC","volume":"100","author":"George","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909465188000_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1530\/ERC-16-0219","article-title":"TERT promoter mutations and long-term survival in patients with thyroid cancer","volume":"23","author":"Kim","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"2026070909465188000_bib9","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2013-3734","article-title":"TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909465188000_bib10","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1210\/jc.2016-3434","article-title":"Refining dynamic risk stratification and prognostic groups for differentiated thyroid cancer with TERT promoter mutations","volume":"102","author":"Kim","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909465188000_bib11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.29934","article-title":"Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients","volume":"122","author":"Song","year":"2016","journal-title":"Cancer"},{"key":"2026070909465188000_bib12","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J Clin Oncol"},{"key":"2026070909465188000_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37899-z","article-title":"Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma","volume":"13","author":"Iizuka","year":"2023","journal-title":"Sci Rep"},{"key":"2026070909465188000_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hed.23615","article-title":"Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the Thyroid Cancer Care Collaborative","volume":"37","author":"Urken","year":"2015","journal-title":"Head Neck"},{"key":"2026070909465188000_bib15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1089\/thy.2016.0648","article-title":"Patterns of initial recurrence in completely resected papillary thyroid carcinoma","volume":"27","author":"Kim","year":"2017","journal-title":"Thyroid"},{"key":"2026070909465188000_bib16","volume-title":"International Agency for Research on Cancer","author":"Sylvia","year":"2022","edition":"8, 5th edn."},{"key":"2026070909465188000_bib17","first-page":"450","article-title":"RAS-mutated cytologically indeterminate thyroid nodules: prevalence of malignancy and behavior under active surveillance","volume":"34","author":"Sfreddo","year":"2024","journal-title":"Thyroid"},{"key":"2026070909465188000_bib18","doi-asserted-by":"crossref","first-page":"e1673","DOI":"10.1210\/clinem\/dgad743","article-title":"The role of age in the risk assessment of differentiated thyroid cancers","volume":"109","author":"Goldner","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909465188000_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294145","article-title":"Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma","volume":"18","author":"Heo","year":"2023","journal-title":"PLoS One"},{"key":"2026070909465188000_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/thy.2016.0350","article-title":"Effects of coexistent BRAF(V600E) and TERT promoter mutations on poor clinical outcomes in papillary thyroid cancer: a meta-analysis","volume":"27","author":"Moon","year":"2017","journal-title":"Thyroid"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/33\/2\/ERC-25-0273.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/33\/2\/ERC-25-0273.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0273\/505887\/erc-25-0273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0273\/505887\/erc-25-0273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:47:01Z","timestamp":1783604821000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/2\/e250273\/75907\/TERT-promoter-mutations-and-recurrence-patterns-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0273","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"article-number":"e250273"}}